These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 23513790)

  • 21. Surveillance for hepatocellular carcinoma in patients with liver cirrhosis in India.
    Aggarwal R
    Trop Gastroenterol; 2008; 29(4):183-6. PubMed ID: 19323085
    [No Abstract]   [Full Text] [Related]  

  • 22. [Echographic detection of hepatocellular carcinoma in patients hospitalized for cirrhosis].
    Roget L; Coppéré H; Richard P; Barthélém C; Veyret C; Audigier JC
    Gastroenterol Clin Biol; 1988 Nov; 12(11):827-32. PubMed ID: 2464520
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinicopathologic features and risk factors for hepatocellular carcinoma: results from a single center in southern Turkey.
    Ozer B; Serin E; Yilmaz U; Gümürdülü Y; Saygili OB; Kayaselçuk F; Boyacioğlu S
    Turk J Gastroenterol; 2003 Jun; 14(2):85-90. PubMed ID: 14614632
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mailed Outreach Invitations Significantly Improve HCC Surveillance Rates in Patients With Cirrhosis: A Randomized Clinical Trial.
    Singal AG; Tiro JA; Murphy CC; Marrero JA; McCallister K; Fullington H; Mejias C; Waljee AK; Pechero Bishop W; Santini NO; Halm EA
    Hepatology; 2019 Jan; 69(1):121-130. PubMed ID: 30070379
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Low use of surveillance and early diagnosis of hepatocellular carcinoma in Norway--a population-based cohort study.
    Eskesen AN; Bjøro K; Aandahl EM; Line PD; Melum E
    Cancer Epidemiol; 2014 Dec; 38(6):741-7. PubMed ID: 25454262
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cost-effectiveness of the surveillance program of hepatocellular carcinoma depends on the medical circumstances.
    Nouso K; Tanaka H; Uematsu S; Shiraga K; Okamoto R; Onishi H; Nakamura S; Kobayashi Y; Araki Y; Aoki N; Shiratori Y
    J Gastroenterol Hepatol; 2008 Mar; 23(3):437-44. PubMed ID: 17683496
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Surveillance for hepatocellular carcinoma: does it work?
    Mallat DB; El-Serag HB
    Am J Gastroenterol; 2002 Oct; 97(10):2676-7. PubMed ID: 12385462
    [No Abstract]   [Full Text] [Related]  

  • 28. Hepatocellular carcinoma, a rapidly increasing public health problem: the Tulane experience 2003-2009.
    Tangutur NK; Medvedev SF; Regenstein F; Balart LA
    J La State Med Soc; 2011; 163(4):185-90. PubMed ID: 21954650
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cost-effectiveness of screening for detection of small hepatocellular carcinoma in western patients with Child-Pugh class A cirrhosis.
    Sarasin FP; Giostra E; Hadengue A
    Am J Med; 1996 Oct; 101(4):422-34. PubMed ID: 8873514
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Effect of Hepatocellular Carcinoma Surveillance in an Urban Population With Liver Cirrhosis.
    Nusbaum JD; Smirniotopoulos J; Wright HC; Dash C; Parpia T; Shechtel J; Chang Y; Loffredo C; Shetty K
    J Clin Gastroenterol; 2015; 49(10):e91-5. PubMed ID: 25751372
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CT and MRI improve detection of hepatocellular carcinoma, compared with ultrasound alone, in patients with cirrhosis.
    Yu NC; Chaudhari V; Raman SS; Lassman C; Tong MJ; Busuttil RW; Lu DS
    Clin Gastroenterol Hepatol; 2011 Feb; 9(2):161-7. PubMed ID: 20920597
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Mass screening for high risk group of hepatocellular carcinoma].
    Kawanishi T; Mima S
    Nihon Rinsho; 2001 Oct; 59 Suppl 6():786-90. PubMed ID: 11762057
    [No Abstract]   [Full Text] [Related]  

  • 33. Hepatocellular carcinoma: an emerging problem with hepatitis C.
    Jeffers L
    J Natl Med Assoc; 2000 Aug; 92(8):369-71. PubMed ID: 10992680
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hepatocellular carcinoma surveillance in patients with alcoholic cirrhosis.
    Jepsen P; Ott P
    Expert Rev Gastroenterol Hepatol; 2012 Dec; 6(6):651-3. PubMed ID: 23237248
    [No Abstract]   [Full Text] [Related]  

  • 35. Surveillance for Hepatocellular Carcinoma.
    Marrero JA
    Clin Liver Dis; 2020 Nov; 24(4):611-621. PubMed ID: 33012448
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hepatocellular Carcinoma Surveillance Among Patients With Cirrhosis in a Population-based Integrated Health Care Delivery System.
    Singal AG; Tiro J; Li X; Adams-Huet B; Chubak J
    J Clin Gastroenterol; 2017 Aug; 51(7):650-655. PubMed ID: 27870642
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hepatocellular carcinoma: epidemiology, surveillance, and diagnosis.
    Sherman M
    Semin Liver Dis; 2010 Feb; 30(1):3-16. PubMed ID: 20175029
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Surveillance for hepatocellular carcinoma in patients with cirrhosis improves outcome.
    Stravitz RT; Heuman DM; Chand N; Sterling RK; Shiffman ML; Luketic VA; Sanyal AJ; Habib A; Mihas AA; Giles HC; Maluf DG; Cotterell AH; Posner MP; Fisher RA
    Am J Med; 2008 Feb; 121(2):119-26. PubMed ID: 18261500
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cost-Effectiveness of Hepatocellular Carcinoma Surveillance: An Assessment of Benefits and Harms.
    Parikh ND; Singal AG; Hutton DW; Tapper EB
    Am J Gastroenterol; 2020 Oct; 115(10):1642-1649. PubMed ID: 32530829
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hepatocellular Carcinoma Screening Associated with Early Tumor Detection and Improved Survival Among Patients with Cirrhosis in the US.
    Singal AG; Mittal S; Yerokun OA; Ahn C; Marrero JA; Yopp AC; Parikh ND; Scaglione SJ
    Am J Med; 2017 Sep; 130(9):1099-1106.e1. PubMed ID: 28213044
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.